KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Cash from Operations (2016 - 2025)

Resmed (RMD) has disclosed Cash from Operations for 17 consecutive years, with 339745000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations rose 10.08% year-over-year to 339745000.0, compared with a TTM value of 1914493000.0 through Dec 2025, up 29.68%, and an annual FY2025 reading of 1751588000.0, up 25.0% over the prior year.
  • Cash from Operations was 339745000.0 for Q4 2025 at Resmed, down from 457321000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 578661000.0 in Q1 2025 and bottomed at 65657000.0 in Q3 2021.
  • Average Cash from Operations over 5 years is 270858150.0, with a median of 277698500.0 recorded in 2023.
  • The sharpest move saw Cash from Operations crashed 145.6% in 2021, then soared 541.0% in 2023.
  • Year by year, Cash from Operations stood at 219879000.0 in 2021, then crashed by 41.5% to 128636000.0 in 2022, then skyrocketed by 112.1% to 272832000.0 in 2023, then grew by 13.12% to 308623000.0 in 2024, then increased by 10.08% to 339745000.0 in 2025.
  • Business Quant data shows Cash from Operations for RMD at 339745000.0 in Q4 2025, 457321000.0 in Q3 2025, and 538766000.0 in Q2 2025.